Compare Globus Medical Inc. Class A Common Stock (GMED) vs Innovative Industrial Properties Inc (IIPR) Price & Performance

Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.

GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.

IIPR trades at $51.43, up 0.47% on the day, exhibiting a bearish technical trend near key support at $51. Fundamentally, the REIT shows high gross margins of 88.35% but faces revenue and net income declines in 2025. Recent news highlights a significant $245 million mezzanine loan commitment, signaling active capital deployment despite sector headwinds.

The outlook is mixed; the stock offers a high dividend yield but carries risks from tenant defaults and volatile earnings. Analyst consensus is cautious with a majority Hold rating. Investors should weigh the attractive valuation metrics against operational challenges in the cannabis real estate sector.